Beneath the Surface at AAD: New data could change practice for PsA with obesity

DENVER — Adults with active psoriatic arthritis and obesity had improvements in disease activity, physical function, weight loss and quality of life with combination ixekizumab plus tirzepatide, according to phase 3 study results.In this Beneath the Surface video interview conducted live at the American Academy of Dermatology Annual Meeting, Joel M. Gelfand, MD, MSCE, FAAD, the James J.